TWST logo

Twist Bioscience (TWST) Cash From Financing

Annual CFF

$6.89 M
+$5.98 M+656.31%

September 30, 2024

Summary

Performance

1-Year Change

+656.31%

3-Year Change

-97.91%

5-Year Change

-95.66%

15-Year Change

-89.2%

TWST Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

52.79%
TWST annual cash flow from financing activities is higher than 52.79% of companies in Healthcare sector

High & Low

All-time High

$329.18 M
TWST annual cash flow from financing activities is currently -97.91% below its historical high of $329.18 million

3-Year Low

$911.00 K
TWST annual cash flow from financing activities is currently +656.31% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2024
TWST previous annual earnings announcement was published on Sep 30, 2024

Next Annual Earnings Report Date

N/A
TWST next annual earnings announcement has not yet been scheduled

OtherTWSTcash flowmetrics:

Annual CFI

-$3.07 M
TWST annual cash flow from investing activities is -$3.07 million

Annual CFO

-$64.09 M
TWST annual cash flow from operations is -$64.09 million

Annual FCF

-$69.17 M
TWST annual free cash flow is -$69.17 million

Annual CAPEX

$5.08 M
TWST annual capital expenditures is $5.08 million

Quarterly CFF

$17.94 M
+$14.32 M+394.73%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+517.06%

3-Year Change

+1874.88%

5-Year Change

+772.34%

TWST Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.54%
TWST quarterly cash flow from financing activities is higher than 89.54% of companies in Healthcare sector

High & Low

All-time High

$326.92 M
TWST quarterly cash flow from financing activities is currently -94.51% below its historical high of $326.92 million

3-Year Low

-$1.47 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
TWST previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
TWST next earnings announcement is scheduled for May 2, 2025

OtherTWSTcash flowmetrics:

Quarterly CFI

-$1.54 M
TWST quarterly cash flow from investing activities is -$1.54 million

Quarterly CFO

-$21.43 M
TWST quarterly cash flow from operations is -$21.43 million

Quarterly FCF

-$23.70 M
TWST quarterly free cash flow is -$23.70 million

Quarterly CAPEX

$2.27 M
TWST quarterly capital expenditures is $2.27 million

TTM CFF

$26.31 M
+$19.42 M+281.81%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+610.04%

3-Year Change

+2004.56%

5-Year Change

-69.98%

TWST TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

67.65%
TWST TTM cash flow from financing activities is higher than 67.65% of companies in Healthcare sector

High & Low

All-time High

$628.60 M
TWST TTM cash flow from financing activities is currently -95.81% below its historical high of $628.60 million

3-Year Low

-$167.00 K

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
TWST previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
TWST next earnings announcement is scheduled for May 2, 2025

OtherTWSTcash flowmetrics:

TTM CFI

-$8.77 M
TWST TTM cash flow from investing activities is -$8.77 million

TTM CFO

-$62.55 M
TWST TTM cash flow from operations is -$62.55 million

TTM FCF

-$68.39 M
TWST TTM free cash flow is -$68.39 million

TTM CAPEX

$5.84 M
TWST TTM capital expenditures is $5.84 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

TWST Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+656.3%+517.1%+610.0%
3 y3 years-97.9%+1874.9%+2004.6%
5 y5 years-95.7%+772.3%-70.0%

TWST Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-97.9%+656.3%-93.4%+1318.2%-90.3%>+9999.0%
5 y5-year-97.9%+656.3%-94.5%+1318.2%-95.8%>+9999.0%
alltimeall time-97.9%+656.3%-94.5%+1198.2%-95.8%>+9999.0%

Twist Bioscience Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2024
-
$17.94 M(+394.7%)
$26.31 M(+281.8%)
Sep 2024
$6.89 M(+656.3%)
$3.63 M(+24.7%)
$6.89 M(+86.0%)
Jun 2024
-
$2.91 M(+59.1%)
$3.71 M(+2624.3%)
Mar 2024
-
$1.83 M(-224.1%)
$136.00 K(-181.4%)
Dec 2023
-
-$1.47 M(-433.3%)
-$167.00 K(-118.3%)
Sep 2023
$911.00 K(-99.7%)
$442.00 K(-166.9%)
$911.00 K(-46.7%)
Jun 2023
-
-$661.00 K(-143.3%)
$1.71 M(+61.4%)
Mar 2023
-
$1.52 M(-486.1%)
$1.06 M(-99.6%)
Dec 2022
-
-$395.00 K(-131.9%)
$271.15 M(+0.2%)
Sep 2022
$270.53 M(-17.8%)
$1.24 M(-194.6%)
$270.53 M(-0.1%)
Jun 2022
-
-$1.31 M(-100.5%)
$270.87 M(-0.2%)
Mar 2022
-
$271.62 M(<-9900.0%)
$271.42 M(>+9900.0%)
Dec 2021
-
-$1.01 M(-164.2%)
$1.25 M(-99.6%)
Sep 2021
$329.18 M
$1.57 M(-305.9%)
$329.18 M(-1.2%)
Jun 2021
-
-$765.00 K(-152.7%)
$333.18 M(-24.6%)
DateAnnualQuarterlyTTM
Mar 2021
-
$1.45 M(-99.6%)
$442.01 M(-29.7%)
Dec 2020
-
$326.92 M(+5765.1%)
$628.60 M(+107.0%)
Sep 2020
$303.73 M(+91.5%)
$5.57 M(-94.8%)
$303.73 M(+0.9%)
Jun 2020
-
$108.06 M(-42.5%)
$301.09 M(+8.6%)
Mar 2020
-
$188.04 M(+9041.3%)
$277.31 M(+216.4%)
Dec 2019
-
$2.06 M(-29.7%)
$87.64 M(-44.7%)
Sep 2019
$158.58 M(+78.5%)
$2.93 M(-96.5%)
$158.58 M(-2.3%)
Jun 2019
-
$84.28 M(-5258.2%)
$162.23 M(+57.8%)
Mar 2019
-
-$1.63 M(-102.2%)
$102.78 M(-35.4%)
Dec 2018
-
$73.00 M(+1008.9%)
$159.16 M(+79.2%)
Sep 2018
$88.82 M(+39.2%)
$6.58 M(-73.5%)
$88.82 M(+8.0%)
Jun 2018
-
$24.83 M(-54.6%)
$82.24 M(+43.3%)
Mar 2018
-
$54.75 M(+1956.6%)
$57.41 M(+2056.6%)
Dec 2017
-
$2.66 M
$2.66 M
Sep 2017
$63.80 M(-8.4%)
-
-
Sep 2016
$69.65 M
-
-

FAQ

  • What is Twist Bioscience annual cash flow from financing activities?
  • What is the all time high annual CFF for Twist Bioscience?
  • What is Twist Bioscience annual CFF year-on-year change?
  • What is Twist Bioscience quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Twist Bioscience?
  • What is Twist Bioscience quarterly CFF year-on-year change?
  • What is Twist Bioscience TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Twist Bioscience?
  • What is Twist Bioscience TTM CFF year-on-year change?

What is Twist Bioscience annual cash flow from financing activities?

The current annual CFF of TWST is $6.89 M

What is the all time high annual CFF for Twist Bioscience?

Twist Bioscience all-time high annual cash flow from financing activities is $329.18 M

What is Twist Bioscience annual CFF year-on-year change?

Over the past year, TWST annual cash flow from financing activities has changed by +$5.98 M (+656.31%)

What is Twist Bioscience quarterly cash flow from financing activities?

The current quarterly CFF of TWST is $17.94 M

What is the all time high quarterly CFF for Twist Bioscience?

Twist Bioscience all-time high quarterly cash flow from financing activities is $326.92 M

What is Twist Bioscience quarterly CFF year-on-year change?

Over the past year, TWST quarterly cash flow from financing activities has changed by +$15.04 M (+517.06%)

What is Twist Bioscience TTM cash flow from financing activities?

The current TTM CFF of TWST is $26.31 M

What is the all time high TTM CFF for Twist Bioscience?

Twist Bioscience all-time high TTM cash flow from financing activities is $628.60 M

What is Twist Bioscience TTM CFF year-on-year change?

Over the past year, TWST TTM cash flow from financing activities has changed by +$22.60 M (+610.04%)